Blackstone Life Sciences announced a $455 million collaboration with Boston Scientific Corporation to co-fund development of the VITALYST Temporary Percutaneous Transvalvular Circulatory Support System. The VITALYST system is a miniature heart pump designed to treat acute myocardial infarction cardiogenic shock by increasing cardiac output and improving blood flow to vital organs. This marks the first co-funding partnership between Boston Scientific and Blackstone Life Sciences for a Boston Scientific product. The collaboration aims to advance a next-generation medical device with improved efficacy, safety, and ease of use.
Company Information
Company
Boston Scientific
Location
300 Boston Scientific Way
Marlborough, Massachusetts, United States
About
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.